Stay updated with breaking news from Marie Utter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has received a consensus recommendation of “Reduce” from the thirteen analysts that are currently covering the firm, Marketbeat reports. Five analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company. The average […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has earned a consensus recommendation of “Reduce” from the fifteen brokerages that are presently covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and three have issued a buy recommendation on the company. […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has received a consensus recommendation of “Reduce” from the fifteen ratings firms that are currently covering the firm, Marketbeat reports. Five equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and three have assigned a buy recommendation to the […]
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) gapped down prior to trading on Friday after Cantor Fitzgerald lowered their price target on the stock from $51.00 to $45.00. The stock had previously closed at $26.66, but opened at $25.71. Cantor Fitzgerald currently has an overweight rating on the stock. PTC Therapeutics shares […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) shares traded down 2.9% on Tuesday . The stock traded as low as $38.61 and last traded at $39.10. 132,714 shares traded hands during trading, a decline of 83% from the average session volume of 801,563 shares. The stock had previously closed at $40.27. Analyst Upgrades and […]